Published in J Control Release on September 07, 2007
Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs. Int J Pharm (2012) 1.25
Folic acid functionalized nanoparticles for enhanced oral drug delivery. Mol Pharm (2012) 0.92
Preparation and evaluation of poly(ethylene glycol)-poly(lactide) micelles as nanocarriers for oral delivery of cyclosporine a. Nanoscale Res Lett (2010) 0.92
Afatinib and its encapsulated polymeric micelles inhibits HER2-overexpressed colorectal tumor cell growth in vitro and in vivo. Oncotarget (2014) 0.88
Vorinostat with sustained exposure and high solubility in poly(ethylene glycol)-b-poly(DL-lactic acid) micelle nanocarriers: characterization and effects on pharmacokinetics in rat serum and urine. J Pharm Sci (2012) 0.80
The effect of dual-functional hyaluronic acid-vitamin E succinate micelles on targeting delivery of doxorubicin. Int J Nanomedicine (2016) 0.75
Biological properties of the angiotensin-converting enzyme inhibitor cilazapril. J Cardiovasc Pharmacol (1985) 1.51
Efficiency of high- and low-voltage pulse combinations for gene electrotransfer in muscle, liver, tumor, and skin. Hum Gene Ther (2008) 1.39
Insect cell culture for industrial production of recombinant proteins. Appl Microbiol Biotechnol (2003) 1.28
The modulation of rat liver carcinogenesis by perfluorooctanoic acid, a peroxisome proliferator. Toxicol Appl Pharmacol (1991) 1.16
DNA electrotransfer into the skin using a combination of one high- and one low-voltage pulse. J Control Release (2005) 1.08
Recombinant interferon-gamma secreted by Chinese hamster ovary-320 cells cultivated in suspension in protein-free media is protected against extracellular proteolysis by the expression of natural protease inhibitors and by the addition of plant protein hydrolysates to the culture medium. In Vitro Cell Dev Biol Anim (2005) 1.05
Ro 32-3555, an orally active collagenase inhibitor, prevents cartilage breakdown in vitro and in vivo. Br J Pharmacol (1997) 1.01
Transdermal delivery of macromolecules using skin electroporation. Pharm Res (2000) 1.01
Dual anticancer drug/superparamagnetic iron oxide-loaded PLGA-based nanoparticles for cancer therapy and magnetic resonance imaging. Int J Pharm (2013) 1.00
Characterization of physico-chemical properties and pharmaceutical performance of sucrose co-freeze-dried solid nanoparticulate powders of the anti-HIV agent loviride prepared by media milling. Int J Pharm (2007) 0.98
Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance. J Control Release (2001) 0.96
Polymeric nanoparticles as delivery system for influenza virus glycoproteins. J Control Release (1998) 0.96
In vitro percutaneous penetration through hairless rat skin: influence of temperature, vehicle and penetration enhancers. Eur J Pharm Biopharm (1998) 0.95
Topical gene transfer into rat skin using electroporation. Pharm Res (2001) 0.90
Metabolic design of macroscopic bioreaction models: application to Chinese hamster ovary cells. Bioprocess Biosyst Eng (2006) 0.89
Cauda equina syndrome: an anatomically driven review. Br J Hosp Med (Lond) (2008) 0.88
(E)-2(R)-[1(S)-(Hydroxycarbamoyl)-4-phenyl-3-butenyl]-2'-isobutyl-2'-(methanesulfonyl)-4-methylvalerohydrazide (Ro 32-7315), a selective and orally active inhibitor of tumor necrosis factor-alpha convertase. J Pharmacol Exp Ther (2002) 0.88
The influence of Myrj 59 on the solubility, toxicity and activity of amphotericin B. J Pharm Pharmacol (1991) 0.88
Trimethylaminuria associated with seizures and behavioural disturbance: a case report. Seizure (1997) 0.88
Intestinal uptake and biodistribution of novel polymeric micelles after oral administration. J Control Release (2006) 0.86
Transdermal delivery of metoprolol by electroporation. Pharm Res (1994) 0.86
Encapsulation of amphotericin B in poly(ethylene glycol)-block-poly(epsilon-caprolactone-co-trimethylenecarbonate) polymeric micelles. Int J Pharm (2006) 0.86
Phenobarbital as a promoter in the initiation/selection process of experimental rat hepatocarcinogenesis. Carcinogenesis (1983) 0.85
On the mechanism of the hepatocarcinogenicity of peroxisome proliferators. Chem Biol Interact (1991) 0.85
A permanently charged tamoxifen derivative displays anticancer activity and improved tissue selectivity in rodents. Cancer Res (1996) 0.84
Lipid stability and meat colour of beef from pasture- and grain-fed cattle with or without vitamin E supplement. Meat Sci (2002) 0.84
Dorsally displaced fractures of the distal radius - a study of preferred treatment options among UK trauma and orthopaedic surgeons. Hand Surg (2010) 0.83
Transdermal delivery of fentanyl: rapid onset of analgesia using skin electroporation. J Control Release (1998) 0.82
Macromolecules as novel transdermal transport enhancers for skin electroporation. Pharm Res (1997) 0.82
Electroperturbation of human stratum corneum fine structure by high voltage pulses: a freeze-fracture electron microscopy and differential thermal analysis study. J Investig Dermatol Symp Proc (1998) 0.82
Comparative analysis of the effect of phenobarbital, dichlorodiphenyltrichloroethane, butylated hydroxytoluene and nafenopin on rat hepatocarcinogenesis. Carcinogenesis (1986) 0.82
Macrophage activation by polymeric nanoparticles of polyalkylcyanoacrylates: activity against intracellular Leishmania donovani associated with hydrogen peroxide production. Pharm Res (1992) 0.82
Prediction of drug solubility in amphiphilic di-block copolymer micelles: the role of polymer-drug compatibility. Pharmazie (2007) 0.81
In vitro identification of targeting ligands of human M cells by phage display. Int J Pharm (2010) 0.81
The use of polymer-based electrospun nanofibers containing amorphous drug dispersions for the delivery of poorly water-soluble pharmaceuticals. Pharmazie (2004) 0.81
Drug targeting with polyalkylcyanoacrylate nanoparticles: in vitro activity of primaquine-loaded nanoparticles against intracellular Leishmania donovani. Ann Trop Med Parasitol (1992) 0.81
Transdermal delivery of fentanyl by electroporation. I. Influence of electrical factors. Pharm Res (1996) 0.80
Comparison of the effects of short, high-voltage and long, medium-voltage pulses on skin electrical and transport properties. J Control Release (1999) 0.80
In vivo tolerance assessment of skin after insertion of subcutaneous and cutaneous microdialysis probes in the rat. Skin Pharmacol Appl Skin Physiol (2003) 0.80
Electroporation-mediated delivery of 3'-protected phosphodiester oligodeoxynucleotides to the skin. J Control Release (2000) 0.80
Factors affecting iontophoretic mobility of metoprolol. J Pharm Sci (1992) 0.80
Flotation equilibrium of serum low density lipoproteins. Anal Biochem (1974) 0.79
Nano-emulsions of fluorinated trityl radicals as sensors for EPR oximetry. J Magn Reson (2008) 0.79
In vivo noninvasive evaluation of hairless rat skin after high-voltage pulse exposure. Skin Pharmacol Appl Skin Physiol (1998) 0.79
Separation of plasma lipids by thin-layer chromatography. Ann Clin Lab Sci (1973) 0.79
Method for measuring the duration of inhibition of angiotensin I-converting enzyme in vivo. J Pharmacol Methods (1981) 0.78
Comparison of the biological effects of phenobarbital and nafenopin on rat hepatocarcinogenesis. Jpn J Cancer Res (1986) 0.78
Characterization of self-assembling copolymers in aqueous solutions using Electron Paramagnetic Resonance and Fluorescence spectroscopy. J Control Release (2006) 0.78
Pyruvate carboxylase deficiency. Report of a case and additional evidence for the "mild" phenotype. Clin Pediatr (Phila) (2001) 0.78
Noninvasive investigation of human skin after in vivo iontophoresis. Skin Pharmacol (1995) 0.78
Transdermal alniditan delivery by skin electroporation. J Control Release (1998) 0.78
Parameters controlling topical delivery of oligonucleotides by electroporation. J Drug Target (1998) 0.78
Study of the gastrointestinal biotransformation of zearalenone in a Caco-2 cell culture system with liquid chromatographic methods. J Appl Toxicol (2008) 0.78
Localization of a FITC-labeled phosphorothioate oligodeoxynucleotide in the skin after topical delivery by iontophoresis and electroporation. Pharm Res (1998) 0.78
Modulation of hepatocarcinogenesis. Annu Rev Pharmacol Toxicol (1991) 0.78
The inhibitory effects of Ro 31-6930 and BRL 38227 on cholinergically-mediated bronchoconstriction in the guinea-pig. Eur J Pharmacol (1993) 0.77
Monoglyceride-based self-assembling copolymers as carriers for poorly water-soluble drugs. Int J Pharm (2009) 0.77
Improved delivery through biological membranes XVI. Enhancement of the brain-specificity of a dihydropyridine formed from pyridinium salt drug delivery system by controlled infusion. J Parenter Sci Technol (1984) 0.77
Promoting effect of oxazepam in rat hepatocarcinogenesis. Carcinogenesis (1987) 0.77
Fanconi syndrome in a patient with a variant of isovaleric acidemia. Int J Pediatr Nephrol (1986) 0.77
Evaluation of different calorimetric methods to determine the glass transition temperature and molecular mobility below T(g) for amorphous drugs. Int J Pharm (2003) 0.77
Peroxisome proliferation and modulation of rat liver carcinogenesis by 2,4-dichlorophenoxyacetic acid, 2,4,5-trichlorophenoxyacetic acid, perfluorooctanoic acid and nafenopin. Carcinogenesis (1990) 0.77
Comparison of ochratoxin A and deoxynivalenol in organically and conventionally produced beers sold on the Belgian market. Food Addit Contam (2006) 0.77
Liquid chromatographic methods for biotransformation studies of ochratoxin A. Biomed Chromatogr (2008) 0.77
Chronic weight loss in lean and obese rats with a brain-enhanced chemical delivery system for estradiol. Physiol Behav (1988) 0.76
Short communication: Ability of cultured mammary epithelial cells in a bicameral system to secrete milk fat. J Dairy Sci (2007) 0.76
Potential of an in vitro toolbox combined with exposure data as a first step for the risk assessment of dietary chemical contaminants. Food Addit Contam Part A Chem Anal Control Expo Risk Assess (2011) 0.76
Comparison of different models of rat liver carcinogenesis: conclusions from a systemic analysis. Toxicol Pathol (1984) 0.76
Transdermal permeation of neutral molecules by skin electroporation. J Control Release (1998) 0.76
Contaminants in organically and conventionally produced winter wheat (Triticum aestivum) in Belgium. Food Addit Contam (2007) 0.76
Diploid growth pattern of hepatocellular tumours induced by various carcinogenic treatments. Carcinogenesis (1991) 0.76
The influence of phenobarbital and butylated hydroxytoluene on the ploidy rate in rat hepatocarcinogenesis. Carcinogenesis (1988) 0.76
Promotion of chemically initiated hepatocarcinogenesis. Prog Clin Biol Res (1982) 0.76
Mechanisms of a phosphorothioate oligonucleotide delivery by skin electroporation. Int J Pharm (1999) 0.75
Intranasal immunization against influenza virus using polymeric particles. J Biomater Sci Polym Ed (1999) 0.75
X-ray scattering analysis of human stratum corneum treated by high voltage pulses. Pharm Res (1997) 0.75
In vivo iontophoresis of fentanyl and sufentanil in rats: pharmacokinetics and acute antinociceptive effects. Anesth Analg (1993) 0.75
Influence of the nature and the dose of the initiator on the development of premalignant and malignant lesions in rat hepatocarcinogenesis. Teratog Carcinog Mutagen (1986) 0.75
Dietary modulation of rat liver carcinogenesis. Carcinogenesis (1987) 0.75
Partial hepatectomy of rats ten weeks before carcinogen administration can enhance liver carcinogenesis: preliminary observations. Carcinogenesis (1988) 0.75
Transdermal drug delivery by skin electroporation in the rat. Methods Mol Med (2000) 0.75
[Comparative systemic analysis of experimental models of chemical hepatic carcinogenesis in the rat]. C R Seances Soc Biol Fil (1984) 0.75
Spontaneously self-assembled micelles from poly(ethylene glycol)-b-poly(epsilon-caprolactone-co-trimethylene carbonate) for drug solubilization. Pharmazie (2008) 0.75
Lipoprotein fractionation by column chromatography. Ann Clin Lab Sci (1972) 0.75
[Promoting effect of portacaval anastomosis in experimental hepatic carcinogenesis]. C R Seances Soc Biol Fil (1984) 0.75
Adenylate cyclase activity in crude liver membranes during chemical hepatocarcinogenesis in portacaval shunted rats. Carcinogenesis (1992) 0.75
A review of 1241 trauma cases: a study of efficiency in trauma theatres. Injury (2008) 0.75
Promoting effect of portocaval anastomosis in rat hepatocarcinogenesis. Carcinogenesis (1984) 0.75
Transdermal delivery of fentanyl by electroporation. II. Mechanisms involved in drug transport. Pharm Res (1996) 0.75
Influence of the duration and the delay of administration of phenobarbital on its modulating effect on rat hepatocarcinogenesis. Carcinogenesis (1987) 0.75
Human calcitonin delivery in rats by iontophoresis. J Pharm Pharmacol (1994) 0.75
Transdermal permeation of alniditan by iontophoresis: in vitro optimization and human pharmacokinetic data. Pharm Res (1996) 0.75